Insights into preclinical models of calcific aortic valve disease and their translational potential
Frontiers in Cardiovascular Medicine · 06.11.2025 · 12
DOI: 10.3389/fcvm.2025.1621990 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 06.11.2025. Verfasst von Isabelle Lafosse und 5 weiteren Autor:innen. Beteiligte Einrichtung: UR UPJV 7517 MP3CV, CURS, Amiens, France. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 219 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Calcific aortic valve disease (CAVD) is characterized by a fibrocalcific remodeling of the aortic valve. This pathology is the most prevalent valvular heart disease worldwide and is associated with a poor prognosis. Despite extensive research, no pharmacological treatments are available to slow or reverse valvular degeneration, making aortic valve replacement the only current therapeutic option. This lack of clinical success may stem from an incomplete understanding of the disease's mechanisms and the limitations of current preclinical models, which do not fully replicate the complexity of CAVD and its associated risk factors and comorbidities. Indeed, while existing models offer valuable insights, a deeper understanding of CAVD requires incorporating comorbidities, gender-specific mechanisms, and dynamic cellular and tissue-level changes. This review aims to provide the reader with an overview of preclinical models developed in recent years to study CAVD, assessing their strengths and limitations. We review how these models can be used to mimic and/or investigate the cellular and molecular mechanisms involved in CAVD development, and highlight how key risk factors and comorbidities can be incorporated to enhance the translational potential of research. We hope that this approach will help guide researchers in selecting the most appropriate model for their studies, with the goal of advancing the identification of effective therapeutic candidates.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- UR UPJV 7517 MP3CV, CURS, Amiens, France.
- Department of Biochemistry and Endocrine Biology, Amiens University Hospital, Amiens, France.
- Department of Pharmacology, Amiens University Hospital, Amiens, France.
- Department of Cardiology, Amiens University Hospital, Amiens, France.
Zitieren
APA
Lafosse, I., Mentaverri, R., Avondo, C., Bennis, Y., Tribouilloy, C., & Hénaut, L. (2025). Insights into preclinical models of calcific aortic valve disease and their translational potential. Frontiers in Cardiovascular Medicine, 12. https://doi.org/10.3389/fcvm.2025.1621990
Vancouver
Lafosse I, Mentaverri R, Avondo C, Bennis Y, Tribouilloy C, Hénaut L. Insights into preclinical models of calcific aortic valve disease and their translational potential. Frontiers in Cardiovascular Medicine. 2025;12. doi:10.3389/fcvm.2025.1621990
BibTeX
@article{Lafosse2025,
author = {Lafosse, Isabelle and Mentaverri, Romuald and Avondo, Carine and Bennis, Youssef and Tribouilloy, Christophe and Hénaut, Lucie},
title = {Insights into preclinical models of calcific aortic valve disease and their translational potential},
journal = {Frontiers in Cardiovascular Medicine},
year = {2025},
volume = {12},
doi = {10.3389/fcvm.2025.1621990}
}
EUVIMED